Related Experiment Videos
Heart transplant for the failing ischaemic ventricle
R Nataf1, I Gandjbakhch, A Pavie
1Department of Cardiovascular Surgery, Hopital de la Pitie, Paris, France.
Insights
Heart transplantation is a proven therapy for heart failure, with advances improving outcomes. Careful patient selection and managing late graft atherosclerosis are key for long-term success in cardiac transplant recipients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Heart transplantation has over 28 years of clinical application.
- Ischaemic heart disease and idiopathic cardiomyopathies are primary indications for cardiac transplant.
- Selecting between heart transplant and coronary revascularization for failing ventricles requires comprehensive assessment.
Purpose of the Study:
- To review the current status and advancements in heart transplantation.
- To highlight the importance of patient selection and management strategies.
- To discuss challenges and future directions in cardiac transplant therapy.
Main Methods:
- Review of clinical experience and published literature on heart transplantation.
- Analysis of diagnostic tools for assessing ventricular function and viability.
- Evaluation of immunosuppressive therapies and rejection detection methods.
Main Results:
- Significant improvements in heart transplant outcomes due to advances in rejection detection, organ preservation, and immunosuppression.
- Haemodynamic, contractile, and viability measurements aid in selecting between transplant and revascularization.
- Late graft atherosclerosis remains a significant challenge despite advancements.
Conclusions:
- Heart transplantation is a successful treatment for end-stage heart failure.
- Ongoing research focuses on mitigating long-term complications like graft atherosclerosis.
- Multidisciplinary management is crucial for optimizing outcomes in cardiac transplant patients.
Abstract:
Clinical application of heart transplantation goes beyond 28 years experience. Ischaemic heart diseases remain, with idiopathic cardiomyopathies, the main indications for cardiac transplant. A combination of haemodynamic, contractile and viability measurements may be useful to choose between transplant and coronary revascularization for the failing ischaemic ventricle. Advances in the detection of early rejection, improved organ preservation procedures, and the introduction of new immunosuppressive therapy protocols have produced dramatic results in heart transplantation. Late graft atherosclerosis remains a serious threat despite retransplantation and, in some cases, mechanical circulatory support.